Top Markets
#1 0G 0G +41.62%
#2 Useless Coin Useless Coin +37.69%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.35%
#4 SAFEcoin SAFEcoin +29.70%
#5 Arbitrum Arbitrum +28.39%
#6 StonkBroker StonkBroker +27.25%
#7 Pons Pons +22.09%
#8 Notcoin Notcoin +20.52%
#9 Zora Zora +18.90%
#10 Full Moon Full Moon +18.20%
Coin of the day
0G 0G
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

RLMD
Classifica tra le azioni #13829
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company... Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Prezzo delle azioni
$4.36
Capitalizzazione di mercato
$457.32M
Variazione (1 giorno)
0.69%
Variazione (1 anno)
289.29%
Paese
US
Scambia Relmada Therapeutics, Inc. (RLMD)

Categoria

Healthcare
Rapporto P/B per Relmada Therapeutics, Inc. (RLMD)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Relmada Therapeutics, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Relmada Therapeutics, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH